Första AP-fonden’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
– Sell
-35,920
Closed -$24.3M – 256
2025
Q4
$24.3M Sell
35,920
-2,480
-6% -$1.69M 0.14% 124
2025
Q3
$24.5M Buy
38,400
+5,400
+16% +$3.28M 0.15% 131
2025
Q2
$17.7M Hold
33,000
– – 0.12% 157
2025
Q1
$13.9M Buy
33,000
+300
+0.9% +$130K 0.1% 172
2024
Q4
$13.5M Buy
32,700
+100
+0.3% +$43.9K 0.1% 188
2024
Q3
$16.5M Buy
32,600
+1,900
+6% +$923K 0.13% 152
2024
Q2
$15M Sell
30,700
-2,100
-6% -$1.05M 0.13% 139
2024
Q1
$17.7M Buy
32,800
+11,600
+55% +$6.34M 0.15% 132
2023
Q4
$11.8M Buy
21,200
+3,200
+18% +$1.5M 0.12% 182
2023
Q3
$7.87M Buy
18,000
+900
+5% +$449K 0.09% 244
2023
Q2
$8.59M Buy
17,100
+200
+1% +$95.8K 0.09% 241
2023
Q1
$8.45M Sell
16,900
-17,300
-51% -$8.28M 0.1% 233
2022
Q4
$14M Buy
34,200
+8,400
+33% +$3.26M 0.16% 135
2022
Q3
$8.41M Sell
25,800
-800
-3% -$294K 0.1% 223
2022
Q2
$9.33M Sell
26,600
-1,000
-4% -$408K 0.12% 181
2022
Q1
$15.1M Sell
27,600
-1,900
-6% -$999K 0.17% 115
2021
Q4
$19.4M Buy
29,500
+1,300
+5% +$816K 0.2% 101
2021
Q3
$17.5M Buy
28,200
+5,100
+22% +$3.43M 0.2% 103
2021
Q2
$14.6M Buy
23,100
+2,900
+14% +$1.6M 0.17% 128
2021
Q1
$9.88M Sell
20,200
-1,400
-6% -$701K 0.14% 178
2020
Q4
$10.8M Buy
21,600
+1,900
+10% +$850K 0.16% 138
2020
Q3
$7.74M Buy
19,700
+6,500
+49% +$2.4M 0.16% 139
2020
Q2
$4.36M Buy
13,200
+1,200
+10% +$347K 0.11% 202
2020
Q1
$2.91M Buy
+12,000
New +$3.13M 0.1% 228

Other funds holding IDXX

Första AP-fonden's IDXX Position: Q1 2026 in Review

Första AP-fonden sold out of Idexx Laboratories (IDXX) in Q1 2026, closing a stake of 35,920 shares — an estimated $24.3M sold.

Första AP-fonden first reported a position in IDXX in Q1 2020 and held it in 24 quarters. The position peaked at $24.5M in Q3 2025. 1,318 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • Första AP-fonden reported no remaining Idexx Laboratories position as of Q1 2026 after selling out during the quarter.
  • Första AP-fonden sold 35,920 Idexx Laboratories shares in Q1 2026, an estimated $24.3M.
  • Första AP-fonden first reported a position in Idexx Laboratories in Q1 2020 and held it in 24 quarters.
  • Första AP-fonden's Idexx Laboratories position peaked at $24.5M in Q3 2025.
  • 1,318 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Första AP-fonden's 13F filing for Q1 2026.